Skip to main content
Premium Trial:

Request an Annual Quote

Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

NEW YORK (GenomeWeb) – Celsee said today that it has entered a co-commercialization agreement with IncellDx for several products, including a 20-marker lung cancer genomics and proteomics panel, a CTC-based screening test for breast, colorectal, prostate, and other cancers, and a cell-based NIPT assay.

The companies said that their announcement follows the successful completion of a feasibility study that analyzed PD-L1 expression in lung cancer biopsy and blood specimens using the IncellDx OncoTect iO Single Cell Quantitative PD-L1 assay and the Celsee C-Prep Genesis platform.

In the study, which was presented last year at the annual meeting of the Association for Molecular Pathology, several patient samples showed a positive expression for PD-L1 in CTCs using the companies' combined technologies, but showed only minimal expression using standard-of- care methods.

"The coupled ability of IncellDx's technology to generate single cell suspensions with Celsee's technology to isolate and analyze single cells derived from peripheral blood and tissue will create a new standard for clinical research and for future diagnostic applications," Celsee CEO John Stark said in a statement.

Financial terms of the agreement were not disclosed.


The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.